Brind.
  1. Bristol Myers Squibb acquired Karuna Therapeutics, and Cristian Massacesi joined BMS as Chief Medical Officer after working at AstraZeneca.
  2. Financial Times reported ongoing deal talks between AstraZeneca and Bristol-Myers Squibb, potentially creating a pharmaceutical giant.

Potential merger discussions involving major pharmaceutical companies like Eli Lilly, AstraZeneca, and AbbVie are underway.

2 reports, 1 independent Updated Aug 3
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Potential merger discussions involving major pharmaceutical companies like Eli Lilly, AstraZeneca, and AbbVie are underway.

Who's involved

What this event is mainly about
Eli Lilly and CompanyAstraZenecaAbbVie

Keep exploring

Part of

Financial Times reported ongoing deal talks between AstraZeneca and Bristol-Myers Squibb, potentially creating a pharmaceutical giant.

Also in this story

All 3 developments

Within Bristol Myers Squibb acquired Karuna Therapeutics, and Cristian Massacesi joined BMS as Chief Medical Officer after working at AstraZeneca.

The entities involved

Related events

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story